Dietary sugars: A fat difference

Journal of Clinical Investigation

Volumn 119, Issue 5, 2009, Pages 1089-1092

  Hofmann, Susanna M ^a   Tschöp, Matthias H ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; FRUCTOSE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN;

BEVERAGE; CARDIOVASCULAR DISEASE; DIETARY INTAKE; DYSLIPIDEMIA; ENERGY BALANCE; ENZYME ACTIVITY; FRUCTOSE METABOLISM; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; HYPERLIPIDEMIA; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPOGENESIS; MORBIDITY; NOTE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SUGAR INTAKE; ADIPOSE TISSUE; BLOOD; CALORIC INTAKE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LIVER; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; POSTPRANDIAL STATE; SEXUAL DEVELOPMENT;

ADIPOSE TISSUE; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIETARY SUCROSE; ENERGY INTAKE; FRUCTOSE; GLUCOSE; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; LIPOPROTEINS; LIVER; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; POSTPRANDIAL PERIOD; RISK FACTORS; SEX CHARACTERISTICS; TRIGLYCERIDES;

EID: 66449086312     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI39332     Document Type: Note

References (19)

1. Prospective Studies Collaboration Group. 2009. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet. Online publication ahead of print. doi:10.1016/S0140-6736(09)60318-4.
2. Wells, F.W., and Busby, J.C. 2008. Dietary assessment of major trends in US food consumption, 1970-2005. Economic Information Bulletin. 33:18.
3. Suga, A., et al. 2000. Effects of fructose and glucose on plasma leptin, insulin, and insulin resistance in lean and VMH-lesioned obese rats. Am. J. Physiol. Endocrinol. Metab. 278:E677-E683.
4. Cha, S.H., Wolfgang, M., Tokutake, Y., Chohnan, S., and Lane, M.D. 2008. Differential effects of central fructose and glucose on hypothalamic malonyl-CoA and food intake. Proc. Natl. Acad. Sci. U. S. A. 105:16871-16875.
5. Stanhope, K.L., et al. 2009. Consuming fructosesweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119:1322-1334.
6. Wolf, A., Bray, G.A., and Popkin, B.M. 2008. A short history of beverages and how our body treats them. Obes. Rev. 9:151-164.
7. White, J.S. 2008. Straight talk about high-fructose corn syrup: what it is and what it ain't. Am. J. Clin. Nutr. 88:1716S-1721S.
8. Livesey, G., and Taylor, R. 2008. Fructose consumption and consequences for glycation, plasma triacylglycerol, and body weight: meta-analyses and meta-regression models of intervention studies. Am. J. Clin. Nutr. 88:1419-1437.
9. Brown, C.M., Dulloo, A.G., and Montani, J.P. 2008. Sugary drinks in the pathogenesis of obesity and cardiovascular diseases. Int. J. Obes. (Lond.). 32(Suppl. 6):S28-S34.
10. Kuo, P.T., and Bassett, D.R. 1965. Dietary sugar in the production of hypertriglyceridemia. Ann. Intern. Med. 62:1199-1212.
11. Mäenpää, P.H., Raivio, K.O., and Kekomaki, M.P. 1968. Liver adenine nucleotides: fructose-induced depletion and its effect on protein synthesis. Science. 161:1253-1254.
12. Cortez-Pinto, H., et al. 1999. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA. 282:1659-1664.
13. Tilg, H., and Moschen, A.R. 2008. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol. Metab. 19:371-379.
14. Choi, H.K., and Curhan, G. 2008. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ. 336:309-312.
15. Kanellis, J., and Kang, D.H. 2005. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin. Nephrol. 25:39-42.
16. Haidari, M., et al. 2002. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J. Biol. Chem. 277:31646-31655.
17. Rader, D.J. 2007. Illuminating HDL - is it still a viable therapeutic target? N. Engl. J. Med. 357:2180-2183.
18. Nagai, Y., et al. 2009. The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab. 9:252-264.
19. Severson, K. 2009 March 20. Sugar is back on food labels, this time as a selling point. The New York Times. http://www.nytimes.com/2009/03/21/ dining/21sugar.html.